Concentra Biosciences to acquire Kronos Bio for $35m.

Synopsis

Concentra Biosciences, a biopharmaceutical company that specializes in acquiring and restructuring distressed or underperforming biotech firms, agreed to acquire Kronos Bio, a biopharmaceutical company for $35m.

Principals

target

Kronos Bio

bidder

Concentra Biosciences

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

gibson dunn & crutcher

HQ - Los Angeles

legal advisors

bidder

1303

Deals

£ 1,081.34 B

Total Value

goodwin procter

HQ - Boston

legal advisors

target

945

Deals

£ 582.75 B

Total Value

leerink partners

financial advisors

target

118

Deals

£ 30.01 B

Total Value

red house consulting

pr advisors

target

Deals

£ 634 M

Total Value